Open AccessCombined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer
Author(s) -
Tao Qin,
Gaili An,
Xinhan Zhao,
Fang Tian,
Xiaohua Li,
Jianqi Lian,
BoRong Pan,
Shanzhi Gu
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.871
Subject(s) - medicine , oxaliplatin , capecitabine , gastroenterology , regimen , nausea , survival rate , fluorouracil , chemotherapy regimen , chemotherapy , surgery , oncology , cancer , colorectal cancer
To investigate the efficacy and side effects of the combined therapy of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer (ESCC) and the survival of the patients.